Nonpeptide Urotensin-II receptor agonists and antagonists: Review and structure-activity relationships

被引:22
|
作者
Lescot, Elodie [1 ]
Bureau, Ronan [1 ]
Rault, Sylvain [1 ]
机构
[1] Univ Caen, UFR Sci Pharmaceut, Ctr Etudes & Rech Medicament Normandie, F-14032 Caen, France
关键词
Urotensin-II; GPR14; nonpeptide agonists and antagonists; GPCR; SAR; pharmacophore;
D O I
10.1016/j.peptides.2007.09.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human Urotensin-II (hU-II) is a cyclic 11-amino acid peptide that plays a role in cardiovascular homeostasis. Its receptor is a member of the class A of G-protein-coupled receptors, called GPR14. In recent years, several nonpeptide ligands have been reported in the literature. Most were identified by high-throughput screening and optimized by medicinal chemistry methods. Other nonpeptide ligands were discovered starting from the 3D structure of hU-II or other ligands. They were identified by a virtual screening approach based on a 3D pharmacophore or by structural similarity with others cyclic peptides. in this review, nonpeptide agonists and antagonists are presented in relation to structure-activity relationships. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:680 / 690
页数:11
相关论文
共 50 条
  • [21] Urotensin core mimics that modulate the biological activity of urotensin-II related peptide but not urotensin-II
    Strack, Martin
    Billard, Etienne
    Chatenet, David
    Lubell, William D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (15) : 3412 - 3416
  • [22] The discovery and structure-activity relationships of nonpeptide, low molecular weight antagonists selective for the endothelin ETB receptor
    Chan, MF
    Kois, A
    Verner, EJ
    Raju, BG
    Castillo, RS
    Wu, CD
    Okun, I
    Stavros, FD
    Balaji, VN
    BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (12) : 2301 - 2316
  • [23] Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II
    Flohr, S
    Kurz, M
    Kostenis, E
    Brkovich, A
    Fournier, A
    Klabunde, T
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (09) : 1799 - 1805
  • [24] Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11)
    Marzola, Erika
    Camarda, Valeria
    Batuwangala, Madura
    Lambert, David G.
    Calo, Girolamo
    Guerrini, Remo
    Trapella, Claudio
    Regoli, Domenico
    Tomatis, Roberto
    Salvadori, Severo
    PEPTIDES, 2008, 29 (05) : 674 - 679
  • [25] Nonpeptide Urotensin-II Receptor Antagonists: A New Ligand Class Based on Piperazino-Phthalimide and Piperazino-Isoindolinone Subunits
    Lawson, Edward C.
    Luci, Diane K.
    Ghosh, Shyamali
    Kinney, William A.
    Reynolds, Charles H.
    Qi, Jenson
    Smith, Charles E.
    Wang, Yuanping
    Minor, Lisa K.
    Haertlein, Barbara J.
    Parry, Tom J.
    Damiano, Bruce P.
    Maryanoff, Bruce E.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (23) : 7432 - 7445
  • [26] Quantitative structure-activity relationships of benzoyliminothiadiazoline derivatives as angiotensin II receptor antagonists
    Hirata, T
    Goto, S
    Tamura, K
    Okuhira, M
    Nagao, Y
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (04) : 385 - 388
  • [27] Structure-activity relationships of lysophosphatidic acid: Synthesis and analysis of Edg receptor agonists and antagonists.
    Santos, WL
    Heise, CE
    Lynch, KR
    Macdonald, TL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U687 - U687
  • [28] Structure-activity relationships of competitive NMDA receptor antagonists
    Cheung, NS
    OCallaghan, D
    Ryan, MC
    Dutton, R
    Wong, MG
    Beart, PM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 313 (1-2) : 159 - 162
  • [29] Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonists
    Ahn, HS
    Arik, L
    Boykow, G
    Burnett, DA
    Caplen, MA
    Czarniecki, M
    Domalski, MS
    Foster, C
    Manna, M
    Stamford, AW
    Wu, YS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (14) : 2073 - 2078
  • [30] Androgen receptor antagonists (antiandrogens): Structure-activity relationships
    Singh, SM
    Gauthier, S
    Labrie, F
    CURRENT MEDICINAL CHEMISTRY, 2000, 7 (02) : 211 - 247